---
title: "現代牧業與富亨農業科技深化合作"
description: "現代牧業與深圳富亨農業科技簽署協議，深化合作，共同開拓精準營養市場，旨在響應「健康中國」戰略，推動乳業消費結構優化。蒙牛指出，現代牧業旗下品牌「三隻小牛」在精準營養領域的努力，體現了蒙牛集團的整體戰略佈局，推動乳製品從基礎營養向精準營養轉變。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/272625294.md"
published_at: "2026-01-15T01:06:23.000Z"
---

# 現代牧業與富亨農業科技深化合作

> 現代牧業與深圳富亨農業科技簽署協議，深化合作，共同開拓精準營養市場，旨在響應「健康中國」戰略，推動乳業消費結構優化。蒙牛指出，現代牧業旗下品牌「三隻小牛」在精準營養領域的努力，體現了蒙牛集團的整體戰略佈局，推動乳製品從基礎營養向精準營養轉變。

現代牧業 (01117.HK) 宣佈與深圳富亨農業科技簽訂協議，計劃深化合作，未來雙方將共同開拓精準營養市場，讓優質精準營養產品更快觸達終端用户，預料是響應「健康中國」戰略及推動乳業消費結構優化升級的具體實踐。

蒙牛 (02319.HK) 表示，現代牧業旗下品牌「三隻小牛」在精準營養領域的深耕，是蒙牛集團整體戰略佈局的縮影，近年全力打造營養健康平台與海外平台，其中營養健康平台正是集團發力精準營養的關鍵引擎，目前正系統性地推動乳製品從提供基礎營養，演變成滿足精準營養的產品。

### Related Stocks

- [01117.HK - 現代牧業](https://longbridge.com/zh-HK/quote/01117.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| China commerce ministry: announces final ruling on anti-subsidy probe into EU dairy products | China commerce ministry: announces final ruling on anti-subsidy probe into EU dairy products | [Link](https://longbridge.com/zh-HK/news/275719801.md) |
| Sadafco FY Profit 477.4 Million Riyals | Saudia Dairy & Foodstuff :SADAFCO -FY NET PROFIT 477.4 MILLION RIYALSSADAFCO FY SALES 3 BILLION RIYALS | [Link](https://longbridge.com/zh-HK/news/275608409.md) |
| Jordan Dairy Says Engineer Ahmad Maher Ahmad Hourani Temporarily Assigned As Acting CFO | JORDAN DAIRY (JODA.AM):JORDAN DAIRY - ENGINEER AHMAD MAHER AHMAD HOURANI TEMPORARILY ASSIGNED AS ACTING CFO | [Link](https://longbridge.com/zh-HK/news/276002144.md) |
| 09:37 ETJUSTFOODFORDOGS EXPANDS VETERINARY NUTRITION EXPERTISE | JustFoodForDogs has expanded its veterinary nutrition expertise by appointing Dr. Chris Margrey, who has achieved DACVIM | [Link](https://longbridge.com/zh-HK/news/275622231.md) |
| Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application | Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application | [Link](https://longbridge.com/zh-HK/news/275893661.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。